Clinical parameters for predicting 3-month FEV1 response of obstructive lung diseases in elderly patients

S. Lee, S. W. Ra, G. R. Chon, K. W. Seo, S. B. Hong, T. S. Shim, C. M. Lim, Y. Koh, S. D. Lee, W. S. Kim, D. S. Kim, W. D. Kim, Y. M. Oh (Seoul, Chungju, Ulsan, Republic Of Korea)

Source: Annual Congress 2009 - Asthma and comorbid conditions
Session: Asthma and comorbid conditions
Session type: Thematic Poster Session
Number: 3411
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Lee, S. W. Ra, G. R. Chon, K. W. Seo, S. B. Hong, T. S. Shim, C. M. Lim, Y. Koh, S. D. Lee, W. S. Kim, D. S. Kim, W. D. Kim, Y. M. Oh (Seoul, Chungju, Ulsan, Republic Of Korea). Clinical parameters for predicting 3-month FEV1 response of obstructive lung diseases in elderly patients. Eur Respir J 2009; 34: Suppl. 53, 3411

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparisons among various QOL assessments and clinical outcomes for one year in elderly patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 66s
Year: 2004

Lung function indices versus symptoms for monitoring the course of the disease in patients with COPD
Source: Annual Congress 2008 - Functionality and metabolism in rehabilitation candidates
Year: 2008

Psychological outcomes from pulmonary rehabilitation in patients with chronic obstructive lung disease
Source: Annual Congress 2010 - The psychological impact and educational issues of chronic lung disease: could we do more?
Year: 2010

Evaluation of adequacy of pharmacological treatment in relation to severity in patients with chronic obstructive pulmonary disease (COPD) and their clinical correlations.
Source: International Congress 2018 – Pharmacological management of COPD
Year: 2018

Prediction of exacerbation in one-year follow-up of patients with chronic obstructive pulmonary disease
Source: Virtual Congress 2020 – Clinical data and COPD management
Year: 2020


Application of an outcome prediction model for hospitalized patients with exacerbation of chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 55s
Year: 2005

Prediction of chronic renal failure in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD: points to ponder
Year: 2014


Frequency of adverse consequences after spirography in patients with chronic obstructive pulmonary disease and concomitant ischemic heart disease
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016

Quality control of lung function testing in the registry for patients with chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Lung function II
Year: 2007


Clinical profile and treatment of elderly patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease. A comparative syudy
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013

Can we predict the outcomes of treatment of patients with severe exacerbation of chronic obstructive pulmonary disease (COPD)?
Source: Eur Respir J 2001; 18: Suppl. 33, 241s
Year: 2001

Relationship between dyspnea and depression in the elderly patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD: points to ponder
Year: 2014

Effect of basic therapy of chronic obstructive pulmonary disease on the clinical course of acute myocardial infarction
Source: International Congress 2014 – Comorbidities
Year: 2014


Effect of long-term treatment with fenspiride on clinical and functional status of patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013


Cardiac biomarkers and outcome in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD exacerbation
Year: 2012


Does FEV1 deteriorate significantly between yearly follow-up assessments in chronic obstructive pulmonary disease?
Source: Annual Congress 2010 - Advances in lung function I
Year: 2010


Comparison of patient-reported outcomes (PROs) during acute exacerbation of chronic obstructive pulmonary disease
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016


Can FEV1% successfully predict respiratory failure/hypercapnea in patients with chronic obstructive pulmonary disease? A prospective study
Source: Eur Respir J 2006; 28: Suppl. 50, 201s
Year: 2006

The association between lung function in adults and future burden of obstructive lung diseases in a long-term follow-up
Source: Virtual Congress 2020 – Diagnosis and management of airways disease in primary care
Year: 2020




Changes in the level of melatonin in patients with varying degrees of severity of chronic obstructive pulmonary disease in conjunction with gastroesophageal reflux disease
Source: International Congress 2014 – Comorbidities
Year: 2014